Array comparative genomic hybridization and its applications in cancer

Nature Genetics

Volumn 37, Issue 6S, 2005, Pages S11-S17

  Pinkel, Daniel ^a   Albertson, Donna G ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROFOLATE REDUCTASE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GENOMIC DNA; METHOTREXATE;

BACTERIAL ARTIFICIAL CHROMOSOME; BREAST CANCER; CANCER; CELL STRAIN HCT116; CHROMOSOME 9; CHROMOSOME LOSS; CHRONIC LYMPHATIC LEUKEMIA; COMPARATIVE GENOMIC HYBRIDIZATION; FERTILIZATION; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DOSAGE; GENE EXPRESSION; GENE FUNCTION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPHOMA; MELANOMA CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SOMATIC CELL; STOMACH CANCER; TISSUE MICROARRAY; X CHROMOSOME;

GENE DOSAGE; HUMANS; NEOPLASMS; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SPECIMEN HANDLING; STATISTICS;

EID: 20044375763     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng1569     Document Type: Article

References (75)

1. Kallioniemi, A. et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258, 818-821 (1992).
2. du Manoir, S. et al. Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum. Genet. 90, 590-610 (1993).
3. Karhu, R., Rummukainen, J., Lorch, T. & Isola, J. Four-color CGH: A new method for quality control of comparative genomic hybridization. Genes Chromosomes Cancer24, 112-118 (1999).
4. Mohapatra, G. et al. Analyses of brain tumor cell lines confirm a simple model of relationships among fluorescence in situ hybridization, DNA index, and comparative genomic hybridization. Genes Chromosomes Cancer 20, 311-319 (1997).
5. Solinas-Toldo, S. et al. Matrix-based comparative genomic hybridization: Biochips to screen for genomic imbalances. Genes Chromosomes Cancer20, 399-407 (1997).
6. Pinkel, D. et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat. Genet. 20, 207-211 (1998).
7. Snijders, A.M. et al. Assembly of microarrays for genome-wide measurement of DNA copy number. Nat. Genet. 29, 263-264 (2001).
8. Hodgson, G. et al. Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas. Nat. Genet. 29, 459-464 (2001).
9. Fiegler, H. et al. DNA microarrays for comparative genomic hybridization based on DOP- PCR amplification of BAC and PAC clones. Genes Chromosomes Cancer 36, 361-374 (2003).
10. Smirnov, D.A., Burdick, J.T., Morley, M. & Cheung, V.G. Method for manufacturing whole-genome microarrays by rolling circle amplification. Genes Chromosomes Cancer 40, 72-77 (2004).
11. Ishkanian, A.S. et al. A tiling resolution DNA microarray with complete coverage of the human genome. Nat. Genet. 36, 299-303 (2004).
12. Li, J. et al. Genomic segmental polymorphisms in inbred mouse strains. Nat. Genet. 36, 952-954 (2004).
13. Pollack, J.R. et al. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat. Genet. 23, 41-46 (1999).
14. Mantripragada, K.K. et al. DNA copy-number analysis of the 22q11 deletion-syndrome region using array-CGH with genomic and PCR-based targets. Int. J. Mol. Med. 13, 273-279 (2004).
15. Dhami, P. et al. Exon array-CGH: Detection of copy number changes at the resolution of individual exons in the human genome. Am. J. Hum. Genet. 76, 750-762 (2005).
16. Brennan, C. et al. High-resolution global profiling of genomic alterations with long oligonucleotide microarray. Cancer Res. 64, 4744-4748 (2004).
17. Carvalho, B., Ouwerkerk, E., Meijer, G.A. & Ylstra, B. High resolution microarray comparative genomic hybridisation analysis using spotted oligonucleotides. J. Clin. Pathol. 57, 644-646 (2004).
18. Lucito, R. et al. Detecting gene copy number fluctuations in tumor cells by microarray analysis of genomic representations. Genome Res. 10, 1726-1736 (2000).
19. Zhao, X. et al. An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays. Cancer Res. 64, 3060-3071 (2004).
20. Zhou, X., Mok, S.C., Chen, Z., Li, Y. & Wong, D.T. Concurrent analysis of loss of heterozygosity (LOH) and copy number abnormality (CNA) for oral premalignancy progression using the Affymetrix 10K SNP mapping array. Hum. Genet. 115, 327-330 (2004).
21. Pinkel, D. & Albertson, D. Array comparative genomic hybridization. Ann. Rev. Genet. Genomics (in the press).
22. Fukiya, S., Mizoguchi, H., Tobe, T. & Mori, H. Extensive genomic diversity in pathogenic Escherichia coli and Shigella strains revealed by comparative genomic hybridization microarray. J. Bacteriol. 186, 3911-3921 (2004).
23. Watanabe, T., Murata, Y., Oka, S. & Iwahashi, H. A new approach to species determination for yeast strains: DNA microarray-based comparative genomic hybridization using a yeast DNA microarray with 6000 genes. Yeast 21, 351-365 (2004).
24. Albertson, D.G. et al. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat. Genet. 25, 144-146 (2000).
25. Sebat, J. et al. Large-scale copy number polymorphism in the human genome. Science 305, 525-528 (2004).
26. Barrett, M.T. et al. Comparative genomic hybridization using oligonucleotide microarrays and total genomic DNA. Proc. Natl. Acad. Sci. USA 101, 17765-17770 (2004).
27. Wang, N.J., Liu, D., Parokonny, A.S. & Schanen, N.C. High-resolution molecular characterization of 15q11-q13 rearrangements by array comparative genomic hybridization (array CGH) with detection of gene dosage. Am. J. Hum. Genet. 75, 267-281 (2004).
28. Lupski, J.R., Roth, J.R. & Weinstock, G.M. Chromosomal duplications in bacteria, fruit flies, and humans. Am. J. Hum. Genet. 58, 21-27 (1996).
29. Eichler, E.E. Segmental duplications: What’s missing, misassigned, and misassembled- and should we care? Genome Res. 11, 653-656 (2001).
30. Emanuel, B.S. & Shaikh, T.H. Segmental duplications: An ‘expanding’ role in genomic instability and disease. Nat. Rev. Genet. 2, 791-800 (2001).
31. Zhang, X. et al. High-resolution mapping of genotype-phenotype relationships in cri du chat syndrome using array comparative genomic hybridization. Am. J. Hum. Genet. 76, 312-326 (2005).
32. Locke, D.P. et al. BAC microarray analysis of 15q11-q13 rearrangements and the impact of segmental duplications. J. Med. Genet. 41, 175-182 (2004).
33. Albertson, D.G. & Pinkel, D. Genomic microarrays in human genetic disease and cancer. Hum. Mol. Genet. 12 special issue 2, R145-R152 (2003).
34. lafrate, A.J. et al. Detection of large-scale variation in the human genome. Nat. Genet. 36, 949-951 (2004).
35. Snijders, A.M. et al. Mapping segmental and sequence variations among laboratory mice using BAC array CGH. Genome Res. 15, 302-311 (2005).
36. Utermann, G. et al. Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)- lipoprotein concentrations in plasma. J. Clin. Invest. 80, 458-465 (1987).
37. DeVries, S. et al. Array-based comparative genomic hybridization from formalin-fixed, I paraffin-embedded breast tumors. J. Mol. Diagn. 7, 1-7 (2005).
38. Snijders, A.M. et al. Rare amplicons implicate misspecification of cell fate in oral squamous cell carcinoma. Oncogene published online, 11 April 2005 (doi:10.1038/sj.onc.1208601).
39. Lage, J.M. et al. Whole genome analysis of genetic alterations in small DNA samples using hyperbranched strand displacement amplification and array-CGH. Genome Res. 13, 294-307 (2003).
40. Hosono, S. et al. Unbiased whole-genome amplification directly from clinical samples. Genome Res. 13, 954-964 (2003).
41. Daigo, Y. et al. Degenerate oligonucleotide primed-polymerase chain reaction-based array comparative genomic hybridization for extensive amplicon profiling of breast cancers: A new approach for the molecular analysis of paraffin-embedded cancer tissue. Am. J. Pathol. 158, 1623-1631 (2001).
42. Wang, G. et al. Balanced-PCR amplification allows unbiased identification of genomic copy changes in minute cell and tissue samples. Nucleic Acids Res. 32, e76 (2004).
43. Guillaud-Bataille, M. et al. Detecting single DNA copy number variations in complex genomes using one nanogram of starting DNA and BAC-array CGH. Nucleic Acids Res. 32, e112 (2004).
44. Tanabe, C. et al. Evaluation of a whole-genome amplification method based on adap- tor-ligation PCR of randomly sheared genomic DNA. Genes Chromosomes Cancer 38, 168-176 (2003).
45. Liu, D. et al. LM-PCR permits highly representative whole genome amplification of DNA isolated from small number of cells and paraffin-embedded tumor tissue sections. Diagn. Mol. Pathol. 13, 105-115 (2004).
46. Wang, G. et al. DNA amplification method tolerant to sample degradation. Genome Res. 14, 2357-2366 (2004).
47. Fridlyand, J., Snijders, A.M., Pinkel, D., Albertson, D.G. & Jain, A.N. Hidden Markov models approach to the analysis of array CGH data. J. Multivariate Anal. 90, 132-153 (2004).
48. Olshen, A.B., Venkatraman, E.S., Lucito, R. & Wigler, M. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 5, 557-572 (2004).
49. Hupe, P., Stransky, N., Thiery, J.P., Radvanyi, F. & Barillot, E. Analysis of array CGH data: From signal ratio to gain and loss of DNA regions. Bioinformatics 20, 3413-3422 (2004).
50. Daruwala, R.S. et al. A versatile statistical analysis algorithm to detect genome copy number variation. Proc. Natl. Acad. Sci. USA 101, 16292-16297 (2004).
51. Wang, P., Kim, Y., Pollack, J., Narasimhan, B. & Tibshirani, R. A method for calling gains and losses in array CGH data. Biostatistics 6, 45-58 (2005).
52. Bocker, T., Ruschoff, J. & Fishel, R. Molecular diagnostics of cancer predisposition: Hereditary non-polyposis colorectal carcinoma and mismatch repair defects. Biochim. Biophys. Acta 1423, 01-010 (1999).
53. Esteller, M. Epigenetic lesions causing genetic lesions in human cancer: Promoter hypermethylation of DNA repair genes. Eur. J. Cancer 36, 2294-2300 (2000).
54. Snijders, A.M. et al. Shaping of tumor and drug-resistant genomes by instability and selection. Oncogene 22, 4370-4379 (2003).
55. O’Hagan, R.C. et al. Telomere dysfunction provokes regional amplification and deletion in cancer genomes. Cancer Cell 2, 149-155 (2002).
56. Waldman, F.M. et al. Chromosomal alterations in ductal carcinomas in situ and their in situ recurrences. J. Natl. Cancer Inst. 92, 313-320 (2000).
57. Albertson, D.G. Profiling breast cancer by array CGH. Breast Cancer Res. Treat. 78, 289-298 (2003).
58. Chin, K. et al. In situ analyses of genome instability in breast cancer. Nat. Genet. 36, 984-988 (2004).
59. Schwaenen, C. et al. Automated array-based genomic profiling in chronic lymphocytic leukemia: Development of a clinical tool and discovery of recurrent genomic alterations. Proc. Natl. Acad. Sci. USA 101, 1039-1044 (2004).
60. Paris, P.L. et al. Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors. Hum. Mol. Genet. 13, 1303-1313 (2004).
61. Callagy, G. et al. Identification and validation of prognostic markers in breast cancer with the complementary use of array-CGH and tissue microarrays. J. Pathol. 205, 388-396 (2005).
62. Weiss, M.M. et al. Genomic alterations in primary gastric adenocarcinomas correlate with clinicopathological characteristics and survival. Cell. Oncol. 26, 307-317 (2004).
63. Martinez-Climent, J.A. et al. Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations. Blood 101, 3109-3117 (2003).
64. Rubio-Moscardo, F. et al. Mantel cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome. Blood published online 17 February 2005 (doi: 10.1182/blood-2004-10-3907).
65. Ioannidis, J.P., Ntzani, E.E., Trikalinos, T.A. & Contopoulos-Ioannidis, D.G. Replication validity of genetic association studies. Nat. Genet. 29, 306-309 (2001).
66. Freedman, M.L. et al. Assessing the impact of population stratification on genetic association studies. Nat. Genet. 36, 388-393 (2004).
67. Pollack, J.R. et al. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc. Natl. Acad. Sci. USA 99, 12963-12968 (2002).
68. Heidenblad, M. et al. Microarray analyses reveal strong influence of DNA copy number alterations on the transcriptional patterns in pancreatic cancer: Implications for the interpretation of genomic amplifications. Oncogene 24, 1794-1801 (2005).
69. Hyman, E. et al. Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res. 62, 6240-6245 (2002).
70. Press, M.F. et al. Evaluation of HER-2/neu gene amplification and overexpression: Comparison of frequently used assay methods in a molecularly characterized cohort of breast cancer specimens. J. Clin. Oncol. 20, 3095-3105 (2002).
71. Maldonado, J.L. et al. Determinants of BRAF mutations in primary melanomas. J. Natl. Cancer Inst. 95, 1878-1890 (2003).
72. Ewart-Toland, A. et al. Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human. Nat. Genet. 34, 403-412 (2003).
73. Zardo, G. et al. Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumors. Nat. Genet. 32, 453-458 (2002).
74. Cox, C. et al. A survey of homozygous deletions in human cancer genomes. Proc. Natl. Acad. Sci. USA 102, 4542-4547 (2005).
75. Huusko, P. et al. Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer. Nat. Genet. 36, 979-983 (2004).